Helius Medical Technologies Inc (HSDT) USD0.001 A

Sell:$0.53Buy:$0.55$0.00 (0.71%)

Prices delayed by at least 15 minutes
Sell:$0.53
Buy:$0.55
Change:$0.00 (0.71%)
Prices delayed by at least 15 minutes
Sell:$0.53
Buy:$0.55
Change:$0.00 (0.71%)
Prices delayed by at least 15 minutes

Company Information

About this company

Helius Medical Technologies, Inc. is a neurotech company in the medical device field. It is focused on neurologic deficits using orally applied technology platform that amplifies the brain’s ability to engage physiologic compensatory mechanisms enhancing the lives of people dealing with neurologic diseases. It develops, licenses, or acquires non-implantable technologies targeted at reducing symptoms of neurological disease or trauma. Its product Portable Neuromodulation Stimulator (PoNS) is a non-implantable medical device, inclusive of a controller and mouthpiece, which delivers mild electrical stimulation to the surface of the tongue to provide treatment of gait deficit and chronic balance deficit. PoNS Therapy is integral to the overall PoNS solution and is the physical therapy applied by patients during use of the PoNS neuromodulation stimulator. PoNS is used as an adjunct to a supervised therapeutic exercise program in patients 22 years of age and over by prescription only.

Key people

Dane C. Andreeff
President, Chief Executive Officer, Director
Jeffrey S. Mathiesen
Chief Financial Officer, Treasurer, Company Secretary, Director
Antonella Favit-Van Pelt
Chief Medical Officer
Blane Walter
Independent Chairman of the Board
Paul Buckman
Independent Director
Sherrie Perkins
Independent Director
Edward M. Straw
Independent Director
Click to see more

Key facts

  • EPIC
    -
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Medical Equipment & Supplies
  • ISIN
    US42328V8019
  • Market cap
    $2.04m
  • Employees
    22
  • Shares in issue
    3.73m
  • Exchange
    NASDAQ
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.